SEC Form 4 · accession 0001140361-16-065745
PLUS THERAPEUTICS, INC. · CNSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John David Harris
Officer — VP and GM Cell Therapy
Period of report
May 13, 2016
Accepted (ET)
May 16, 2016 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001095981
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 13, 2016 | P | 2,000 | $2.71 | A | 2,000 | D |
Table II — derivative securities
No Table II lines on this filing.